TOP STORIES

• REGULATORY LDP, Ishin Still at Odds on Social Security Reform; Pharma Role in Chuikyo Gains Traction
  June 19, 2026

• ORGANIZATION Japanese Drug Makers Step Up Use of ASEAN Reliance Reviews
  June 18, 2026

• BUSINESS Teijin to Divest Feburic, Bonalon, Other Legacy Brands to LTL
  June 18, 2026

• REGULATORY New Chuikyo Payer Rep Wary of Blanket Inflation Adjustment for Reimbursement
  June 17, 2026

• REGULATORY CEA Review Group Discusses Evidence for Additional Usefulness
  June 17, 2026

• REGULATORY Japan Sets 6-Billion-Yen Donation Target for Drug Discovery Fund
  June 17, 2026

• COMMENTARY Adaptation, Diversification Key as Drug Wholesalers Face Profit Squeeze
  June 16, 2026

• ORGANIZATION Ease Foreign Price Adjustment Rules for New Drugs to Counter MFN Policy: FPMAJ
  June 15, 2026

• REGULATORY Pharma Wages Multi-Front Lobbying amid Push for Leaner Honebuto
  June 12, 2026

• REGULATORY Revolade, Bilanoa See First Generics in June Listing; 3 Final AGs on Roster
  June 11, 2026

• ACADEMIA Urine-Derived Stem Cells Eyed as New Drug Discovery Tool
  June 10, 2026

• REGULATORY Ishin Proposes Adding Drug, Device Makers to Chuikyo, LDP Wary
  June 10, 2026

• REGULATORY Cabinet Approves Immunization Act Revision to Cover Antibody Drugs
  June 10, 2026

• BUSINESS Moderna Japan Looks Beyond COVID for Next Growth Pillars
  June 9, 2026

• BUSINESS Oncolys Targets 300 Hospitals for Telomelysin Rollout
  June 9, 2026

• REGULATORY Japan Govt Likely to Slim Down Honebuto, but Details Remain Elusive
  June 8, 2026

• BUSINESS Takeda Swings to Loss after Booking Amitiza Litigation Charge
  June 8, 2026

• REGULATORY Ex-GSK Japan Head Calls for End to "Obsolete" 14-Day Prescription Limit
  June 5, 2026

• REGULATORY Trazenta Generic Outlook Remains Clouded as Court Upholds Treatment-Method Patents
  June 4, 2026

• BUSINESS Boehringer’s Japan Pharma Sales Up for 7th Straight Year, 10-Plus Launches Eyed by 2030
  June 4, 2026

ページ

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• …
• Next ›
• 最終 »